Simpson Thacher Represents Initial Purchasers in $1.5 Billion Notes Offering by Roche
03.11.21
This is only gets display when printing
Simpson Thacher represented the initial purchasers, as joint book-running managers, in connection with an offering of Notes by Roche Holdings, Inc. (“Roche”). The offering consisted of a Rule 144A and Regulation S offering of US$500 million aggregate principal amount of 0.45% notes due 2024, US$650 million aggregate principal amount of 0.991% notes due 2026 and US$350 million aggregate principal amount of floating rate notes due 2024 (together, the “Notes”). The offering closed on March 5, 2021. The net proceeds from the issue of the Notes will be used for Roche’s general corporate purposes.
The Roche Group is the world’s leading supplier of in vitro diagnostics, the world’s largest biotech company and the world’s leading provider of cancer treatments.
The Simpson Thacher team included Mark Brod, Pieter Lavens and Melchor Alvarez de Mon (Capital Markets); Michael R. Isby and Vanessa Burrows (Corporate); Alysha Sekhon and Bobbie Burrows (IP); and Jonathan Cantor and Suzy Yaster (Tax).